Annekathryn Goodman

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Gini F. Fleming, Virginia L. Brunetto, David Cella et al. · Journal of Clinical Oncology · 2004 · 561 citations · Full text

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

Richard T. Penson, K. Kronish, Zhenfeng Duan et al. · International Journal of Gynecological Cancer · 2000 · 194 citations

Homogeneous Sampling Accounts for the Increased Diagnostic Accuracy Using the ThinPrep^™Processor

Martha L. Hutchinson, Louise M. Isenstein, Annekathryn Goodman et al. · American Journal of Clinical Pathology · 1994 · 191 citations

Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer

Kristina Williams, Sana Intidhar Labidi‐Galy, Kathryn L. Terry et al. · Gynecologic Oncology · 2014 · 171 citations · Full text

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +7

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

Richard T. Penson, Esther Oliva, Steven J. Skates et al. · Gynecologic Oncology · 2004 · 161 citations

Paclitaxel Response, Serial Samples, Medicine +9